SharpMed

SharpMed

Closed: Nov. 2024

About this raise

SharpMed is raising funds on Republic. The company makes transformative medical devices and delivers advanced and cost-effective medical devices to hospitals. SharpMed’s flagship product, Turbo O2 Cap, has FDA Class 1 clearance and will work as a lifeline in critical moments by preventing dangerous drops in oxygen levels during intubation. The product of SharpMed is 95% ready and is ready for its commercial launch in 2024. Dr. Chris Salvino founded SharpMed in December 2015. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.2 million. The campaign proceeds will be used for new product marketing, research and development, new hires, and general working capital.

Expand

Investment Overview

Invested this round: $212,160

Deal Terms

Total Commitments ($USD)

Platform
Republic
Start Date
05/23/2024
Close Date
11/15/2024
Min. Goal
$50,000
Max Goal
$1,200,000
Min. Investment

$100

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.00

Pre-Money Valuation

$22,090,000

Company & Team

Company

Year Founded
2015
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Scottsdale, Arizona
Business Type
Growth
Company Website
Visit Website

Team

Employees
2
Prior Founder Exits?
No

Financials

as of Fiscal Year 2023
 Revenue
$0
 Monthly Burn
$2,252
 Runway
2 months

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-1,041,555

$-2,702,404

Summary Balance Sheet

FY 2023 FY 2022

Cash

$73,268

$21,882

Accounts Receivable

$0

$0

Total Assets

$312,773

$531,945

Short-Term Debt

$3,846,594

$3,439,211

Long-Term Debt

$2,436,533

$2,436,533

Total Liabilities

$6,283,127

$5,875,744

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
11/15/2024 Republic $22,090,000 $212,160 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
SharpMed on Republic 2024
Platform: Republic
Security Type: Equity - Common
Valuation: $22,090,000
Price per Share: $2.00

Follow company

Follow SharpMed on Republic 2024

Buy SharpMed's Deal Report

Warning: according to the close date for this deal, SharpMed may no longer be accepting investments.

SharpMed Deal Report

Get Kingscrowd's comprehensive report on SharpMed including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether SharpMed is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the SharpMed deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge